Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
Clinical trial NCT00870584 · COMPLETED
Trial details
- NCT number
- NCT00870584
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-03-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.